oxybutynin has been researched along with Frigidity in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Excerpt | Relevance | Reference |
---|---|---|
"sexual activity, orgasm, Profile of Female Sexual Function domains (desire), personal distress score, adverse events, acne, increased hair growth, facial hair, alopecia, voice deepening, urinary symptoms, breast pain, headache, site reaction, total adverse events, serious adverse events, withdrawal from study, and follow-up rate." | 2.55 | Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. ( Achilli, C; Hamoda, H; Panay, N; Pundir, J; Ramanathan, P; Sabatini, L, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gera, R | 1 |
Tayeh, S | 1 |
Chehade, HE | 1 |
Mokbel, K | 1 |
Achilli, C | 1 |
Pundir, J | 1 |
Ramanathan, P | 1 |
Sabatini, L | 1 |
Hamoda, H | 1 |
Panay, N | 1 |
2 reviews available for oxybutynin and Frigidity
Article | Year |
---|---|
Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review.
Topics: Administration, Cutaneous; Breast Neoplasms; Female; Humans; Menopause; Risk Factors; Sexual Dysfunc | 2018 |
Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
Topics: Administration, Cutaneous; Androgens; Chi-Square Distribution; Female; Humans; Odds Ratio; Orgasm; P | 2017 |